BillTrack50 logo
Free Signup Login
Bill

Bill > HB4166

MI HB4166

MI HB4166
Crimes: drugs; illicit use of xylazine; prohibit, and provide penalties. Amends secs. 7103, 7105, 7106, 7401, 7403, 7403a, 7451, 7453 & 7455 of 1978 PA 368 (MCL 333.7103 et seq.).

summary

Introduced
03/05/2025
In Committee
03/05/2025
Crossed Over
Passed
Dead

Introduced Session

103rd Legislature

Bill Summary

A bill to amend 1978 PA 368, entitled"Public health code,"by amending sections 7103, 7105, 7106, 7401, 7403, 7403a, 7451, 7453, and 7455 (MCL 333.7103, 333.7105, 333.7106, 333.7401, 333.7403, 333.7403a, 333.7451, 333.7453, and 333.7455), section 7103 as amended by 1988 PA 60, section 7105 as amended by 1993 PA 80, section 7106 as amended by 2021 PA 60, section 7401 as amended by 2016 PA 548, section 7403 as amended by 2016 PA 307, section 7403a as added by 2010 PA 354, section 7451 as added by 1988 PA 139, section 7453 as amended by 2024 PA 18, and section 7455 as amended by 2024 PA 19.

AI Summary

This bill addresses the regulation and criminalization of xylazine, a veterinary sedative increasingly used illicitly in drug mixtures. The bill amends multiple sections of Michigan's Public Health Code to define "illicit use" of xylazine and establish legal penalties for its unauthorized possession, distribution, and use. Specifically, the bill defines "licit use" of xylazine as legitimate veterinary and pharmaceutical applications, such as animal medical treatments and pharmaceutical research, while criminalizing other uses. The legislation creates new criminal penalties for possessing, manufacturing, or selling xylazine for non-approved purposes, with potential felony charges carrying up to 5 years in prison and fines up to $15,000. The bill also expands definitions of drug paraphernalia to include items specifically related to xylazine's illicit use and updates various sections of the law to incorporate xylazine alongside existing controlled substance regulations. These changes reflect growing concerns about xylazine's emergence as a dangerous adulterant in the illicit drug supply, particularly in combination with opioids, and aim to provide law enforcement and public health officials with tools to address its misuse.

Committee Categories

Justice

Sponsors (57)

Kelly Breen (D)*,  Joey Andrews (D),  Brian BeGole (R),  Matthew Bierlein (R),  Ken Borton (R),  Will Bruck (R),  Erin Byrnes (D),  Brenda Carter (D),  Tyrone Carter (D),  Jennifer Conlin (D),  Emily Dievendorf (D),  Kimberly Edwards (D),  Alabas Farhat (D),  John Fitzgerald (D),  Steve Frisbie (R),  Carol Glanville (D),  Mike Harris (R),  Peter Herzberg (D),  Mike Hoadley (R),  Kara Hope (D),  Jason Hoskins (D),  Gina Johnsen (R),  Matt Koleszar (D),  Tom Kunse (R),  Tullio Liberati (D),  Rylee Linting (R),  Matt Longjohn (D),  Sharon MacDonell (D),  David Martin (R),  Jaz Martus (D),  Mike McFall (D),  Luke Meerman (R),  Jason Morgan (D),  Mike Mueller (R),  Cynthia Neeley (D),  Amos O'Neal (D),  Veronica Paiz (D),  Angela Rigas (R),  Ron Robinson (R),  Julie Rogers (D),  J.R. Roth (R),  Kathy Schmaltz (R),  Helena Scott (D),  Phil Skaggs (D),  Alicia St. Germaine (R),  Samantha Steckloff (D),  Jamie Thompson (R),  Mark Tisdel (R),  Penelope Tsernoglou (D),  Curt VanderWall (R),  Regina Weiss (D),  Jimmie Wilson (D),  Angela Witwer (D),  Stephen Wooden (D),  Doug Wozniak (R),  Mai Xiong (D),  Stephanie Young (D), 

Last Action

Bill Electronically Reproduced 03/05/2025 (on 03/06/2025)

bill text

bill summary

Loading...

bill summary

Loading...
Loading...